MetroPac Movers handling COVID-19 vaccines
Louella Desiderio (The Filipino Star) – March 6, 2021 – 12:00 p.m.
MANILA, Philippines – MVP Group’s logistics arm MetroPac Movers Inc. (MMI) also handled the 487,200 doses of AstraZeneca vaccines that arrived in the country Thursday.
The new shipment follows MMI’s successful handling of 600,000 Sinovac vaccines that arrived on February 28th.
“During the period of closure, our Metropac Movers team ensured a constant supply of important goods by keeping our warehouse operational around the clock. Having received this important task of preserving and ensuring the integrity of vaccines from Sinovac and AstraZeneca, we are honored to contribute to our country’s economic recovery, ”said River Ho Rathore, MMI’s chief operations and transformation officer.
The AstraZeneca vaccines arrived at the company’s facility in Marikina City on March 4th.
Vaccine Czar Secretary Carlito Galvez Jr., Health Secretary Francisco Duque III, and Marikina Mayor Marcy Teodoro reaffirmed MMI’s ability to handle AstraZeneca cans during their respective inspections and site visits.
The Marikina LGU also pledged its full support to ensure that vaccines enter and exit MMI’s Marikina facility unimpeded for the introduction of vaccines to various hospitals. The Philippines expects 5.6 million doses of COVID-19 vaccines from at least two manufacturers in the first quarter. For the remainder of 2021, the government hopes to source 148 million doses and vaccinate two-thirds of the population.
By February 2021, news outlets are reporting that the country is sourcing 30 million doses of Covovax and up to 20 million doses of Moderna vaccines.
As with the first batch of vaccines, MMI and the Ministry of Health signed the Vaccine Handling Procedures Manual and conducted simulation training for obtaining the AstraZeneca vaccine with key staff from DOH, the Research Institute of Tropical Medicine and UNICEF.
MMI Marikina has cold rooms that can withstand temperatures of up to 2 degrees Celsius and meet the storage requirements of brands such as Covovax and Moderna.
Other parts of the 3.2 hectare MMI warehouse can store products that require temperatures between 15 and 25 degrees Celsius.